COMMUNIQUÉS West-GlobeNewswire

-
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results
02/08/2024 -
Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
02/08/2024 -
Algernon Pharmaceuticals Announces Closing of Private Placement
02/08/2024 -
Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
02/08/2024 -
The Ensign Group Grows in Colorado
02/08/2024 -
BrightSpring Health Services, Inc. Reports Second Quarter 2024 Financial Results and Increases Full Year 2024 Guidance
02/08/2024 -
The Ensign Group Acquires Skilled Nursing Facility in Iowa
02/08/2024 -
The Ensign Group Acquires Skilled Nursing Facility in Colorado
02/08/2024 -
EUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICS
02/08/2024 -
EUROBIO SCIENTIFIC FINALISE L’ACQUISITION DU TEST GÉNOMIQUE ENDOPREDICT® AUPRÈS DE MYRIAD GENETICS
02/08/2024 -
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds
02/08/2024 -
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/08/2024 -
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/08/2024 -
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
01/08/2024 -
FDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL Treatment
01/08/2024 -
La FDA accorde le statut de médicament orphelin à CLLS52 (alemtuzumab) de Cellectis pour le traitement de la LLA
01/08/2024 -
Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
01/08/2024 -
The Pennant Group Announces New $250 Million Credit Facility
01/08/2024 -
CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
01/08/2024
Pages